Biosimilars Boost In Europe: 2017 Kicks Off With Three Approvals And Backing From ESMO

 
• By Ian Schofield
  
Reducing costs
Greater use of biosimilars, particularly in cancer, can save on healthcare costs
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics